Inventor · disambiguated record
Albert W. Garofalo
Also filed as: GAROFALO ALBERT · GAROFALO ALBERT W
20 granted patents·18 pending applications·63 citations·filing 1990–2022
93Inventor score
Files withELAN PHARM INC11REDWOOD BIOSCIENCE INC8ESCAPE BIO INC4AN2H DISCOVERY LTD3KONRADI ANDREI W2
Top patents by PatentIndex Score
38 records- 0193US10604483B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2019·Granted Mar 31, 2020·5 cites·16 claims
- 0292US10464894B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2016·Granted Nov 5, 2019·5 cites·14 claims
- 0392US9493413B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2014·Granted Nov 15, 2016·8 cites·17 claims
- 0489US11180451B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2019·Granted Nov 23, 2021·2 cites·20 claims
- 0588US11097013B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2018·Granted Aug 24, 2021·3 cites·29 claims
- 0684US10308617B2Triazole benzamide derivatives and the compositions and methods of treatment regarding the sameAN2H DISCOVERY LTD·Filed 2017·Granted Jun 4, 2019·3 cites·16 claims
- 0777US7754712B2Bridged N-cyclic sulfonamido inhibitors of gamma secretaseELAN PHARM INC·Filed 2007·Granted Jul 13, 2010·2 cites·27 claims
- 0876US7345056B2Bridged N-cyclic sulfonamido inhibitors of gamma secretaseELAN PHARM INC·Filed 2006·Granted Mar 18, 2008·2 cites·20 claims
- 0975US12215080B2Hydrazinyl-pyrrolo compounds and methods for producing a conjugateREDWOOD BIOSCIENCE INC·Filed 2021·Granted Feb 4, 2025·0 cites·21 claims
- 1075US7417152B24-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseasesELAN PHARM INC·Filed 2004·Granted Aug 26, 2008·8 cites·11 claims
- 1174US7732609B25-(arylsulfonyl)-pyrazolopiperidinesELAN PHARM INC·Filed 2006·Granted Jun 8, 2010·2 cites·20 claims
- 1270US7432379B2Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonistsELAN PHARM INC·Filed 2004·Granted Oct 7, 2008·5 cites·12 claims
- 1369US12076411B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2021·Granted Sep 3, 2024·0 cites·27 claims
- 1469US10124070B2Anti-HER2 antibody-maytansine conjugates and methods of use thereofREDWOOD BIOSCIENCE INC·Filed 2015·Granted Nov 13, 2018·1 cites·26 claims
- 1565US5062995APolymeric carbamate detergent buildersLEVER BROTHERS CO·Filed 1990·Granted Nov 5, 1991·15 cites·49 claims
- 1663US7759382B2Acylated amino acid amidyl pyrazoles and related compoundsELAN PHARM INC·Filed 2004·Granted Jul 20, 2010·1 cites·10 claims
- 1758US11427558B1Indazoles and azaindazoles as LRRK2 inhibitorsESCAPE BIO INC·Filed 2020·Granted Aug 30, 2022·0 cites·18 claims
- 1858US9884828B2Substituted cinnolines as inhibitors of LRRK2 kinase activityAUBELE DANIELLE L·Filed 2012·Granted Feb 6, 2018·1 cites·23 claims
- 1958US2016024071A1Inhibitors of lrrk2 kinase activityELAN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2055US2023077268A1Indazoles and azaindazoles as lrrk2 inhibitorsESCAPE BIO INC·Filed 2022·Application pending·0 cites
- 2155US2021163489A1Pyrazolopyrimidine derivatives and the compositions and methods of treatment regarding the sameNYSNOBIO IRELAND DAC·Filed 2021·Application pending·0 cites
- 2251US8283358B2N-sulfonamido polycyclic pyrazolyl compoundsKONRADI ANDREI W·Filed 2009·Granted Oct 9, 2012·0 cites·24 claims
- 2351US2020317674A1Pyrazolopyrimidine derivatives and the compositions and methods of treatment regarding the sameAN2H DISCOVERY LTD·Filed 2017·Application pending·0 cites
- 2451US2007123531A14-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseasesELAN PHARM INC·Filed 2004·Application pending·0 cites
- 2551US2007161633A14-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseasesELAN PHARM INC·Filed 2004·Application pending·0 cites
- 2650US7977368B2Pyrazolopyrrolidines as inhibitors of gamma secretaseELAN PHARM INC·Filed 2008·Granted Jul 12, 2011·0 cites·9 claims
- 2750US2005032868A1Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonistsFiled 2004·Application pending·0 cites
- 2850US2005038099A1Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonistsFiled 2004·Application pending·0 cites
- 2949US2019359578A1Triazole benzamide derivatives and the compositions and methods of treatment regarding the sameAN2H DISCOVERY LTD·Filed 2018·Application pending·0 cites
- 3048US2011003802A1Bridged N-Cyclic Sulfonamido Inhibitors of Gamma SecretaseELAN PHARM INC·Filed 2010·Application pending·0 cites
- 3145US2008021056A1Fused, Tricyclic Sulfonamide Inhibitors of Gamma SecretaseKONRADI ANDREI W·Filed 2007·Application pending·0 cites
- 3244US2018258083A1Inhibitors of lrrk2 kinase activityIMAGO PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3342US2023148214A1Indazoles and azaindazoles as lrrk2 inhibitorsESCAPE BIO INC·Filed 2021·Application pending·0 cites
- 3442US2010280066A1Acylated amino acid amidyl pyrazoles and related compoundsTUNG JAY S·Filed 2010·Application pending·0 cites
- 3542US2010267747A15-(Arylsulfonyl)-PyrazolopiperidinesELAN PHARM INC·Filed 2010·Application pending·0 cites
- 3639US2022162192A1Indazoles as lrrk2 inhibitorsESCAPE BIO INC·Filed 2020·Application pending·0 cites
- 3739US2007032475A1Novel compounds useful for bradykinin B1 receptor antagonismYE XIAOCONG M·Filed 2006·Application pending·0 cites
- 3834US2021261553A1Fused tetrazoles as lrrk2 inhibitorsE SCAPE BIO INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →